Target Name: SEPT5-GP1BB
NCBI ID: G100526833
Other Name(s): GPIb-beta | SEPT5-GP1BB readthrough | GP1BB | GPIbB | SEPT5-GP1BB variant 1 | SEPT5-GP1BB readthrough, transcript variant 1

SEPT5-GP1BB: A Potential Drug Target and Biomarker

SEPT5-GP1BB is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a key regulator of the cell cycle and has been implicated in a number of cellular processes. In recent years, researchers have discovered that SEPT5-GP1BB is also a potential drug target and biomarker.

The cell cycle is the process by which cells grow, divide, and replicate their genetic material. The cell cycle is regulated by a complex network of proteins, includingSEPT5-GP1BB. This protein plays a critical role in controlling the rate at which cells divide and in preventing cell proliferation.

SEPT5-GP1BB is a transcription factor that is involved in the regulation of gene expression. It is composed of two distinct domains: a N-terminal domain that contains a protein-coding region and a C-terminal domain that contains a zinc finger transcription factor-like domain. The N-terminal domain is responsible for binding to DNA and the C-terminal domain is responsible for interacting with other proteins.

SEPT5-GP1BB has been shown to play a role in the regulation of cellular processes that are important for human health. For example, studies have shown that SEPT5-GP1BB is involved in the regulation of cell proliferation, differentiation, and apoptosis. It has also been shown to play a role in the development and progression of a number of diseases, including cancer.

In addition to its role in cellular processes, SEPT5-GP1BB has also been shown to be a potential drug target. Researchers have identified several potential drug candidates that are designed to interact with SEPT5-GP1BB and inhibit its activity. These drugs have the potential to treat a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

SEPT5-GP1BB is also a potential biomarker for a number of diseases. Its expression has been shown to be elevated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that SEPT5-GP1BB may be a useful biomarker for these diseases and could potentially serve as a target for diagnostic tests.

In conclusion, SEPT5-GP1BB is a protein that is involved in the regulation of the cell cycle and has been implicated in a number of cellular processes. In recent years, researchers have discovered that SEPT5-GP1BB is also a potential drug target and biomarker. Its properties and functions continue to be an active area of research, and its potential as a drug target and biomarker should be further explored.

Protein Name: SEPT5-GP1BB Readthrough

More Common Targets

SEPTIN1 | SEPTIN10 | SEPTIN11 | SEPTIN12 | SEPTIN14 | SEPTIN2 | SEPTIN3 | SEPTIN4 | SEPTIN4-AS1 | SEPTIN5 | SEPTIN6 | SEPTIN7 | SEPTIN7-DT | SEPTIN7P11 | SEPTIN7P14 | SEPTIN7P2 | SEPTIN7P6 | SEPTIN7P9 | SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2 | SERTAD1 | SERTAD2 | SERTAD3 | SERTAD4 | SERTAD4-AS1 | SERTM1 | SERTM2 | Serum amyloid protein | SESN1 | SESN2 | SESN3 | SESTD1 | Sestrin | SET | SET1 histone methyltransferase complex | SETBP1 | SETBP1-DT | SETD1A | SETD1B | SETD2 | SETD3